BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36113098)

  • 1. Cost-Effectiveness and Value-of-Information Analysis Using Machine Learning-Based Metamodeling: A Case of Hepatitis C Treatment.
    McCandlish JA; Ayer T; Chhatwal J
    Med Decis Making; 2023 Jan; 43(1):68-77. PubMed ID: 36113098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing and Validating Metamodels of a Microsimulation Model of Infant HIV Testing and Screening Strategies Used in a Decision Support Tool for Health Policy Makers.
    Soeteman DI; Resch SC; Jalal H; Dugdale CM; Penazzato M; Weinstein MC; Phillips A; Hou T; Abrams EJ; Dunning L; Newell ML; Pei PP; Freedberg KA; Walensky RP; Ciaranello AL
    MDM Policy Pract; 2020; 5(1):2381468320932894. PubMed ID: 32587893
    [No Abstract]   [Full Text] [Related]  

  • 3. Choosing a Metamodel of a Simulation Model for Uncertainty Quantification.
    de Carvalho TM; van Rosmalen J; Wolff HB; Koffijberg H; Coupé VMH
    Med Decis Making; 2022 Jan; 42(1):28-42. PubMed ID: 34098793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial neural network metamodel for sensitivity analysis in a total hip replacement health economic model.
    Alam MF; Briggs A
    Expert Rev Pharmacoecon Outcomes Res; 2020 Dec; 20(6):629-640. PubMed ID: 31491359
    [No Abstract]   [Full Text] [Related]  

  • 5. Introduction to Metamodeling for Reducing Computational Burden of Advanced Analyses with Health Economic Models: A Structured Overview of Metamodeling Methods in a 6-Step Application Process.
    Degeling K; IJzerman MJ; Lavieri MS; Strong M; Koffijberg H
    Med Decis Making; 2020 Apr; 40(3):348-363. PubMed ID: 32428428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using Metamodeling to Identify the Optimal Strategy for Colorectal Cancer Screening.
    Koffijberg H; Degeling K; IJzerman MJ; Coupé VMH; Greuter MJE
    Value Health; 2021 Feb; 24(2):206-215. PubMed ID: 33518027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metamodeling for Policy Simulations with Multivariate Outcomes.
    Zhong H; Brandeau ML; Yazdi GE; Wang J; Nolen S; Hagan L; Thompson WW; Assoumou SA; Linas BP; Salomon JA
    Med Decis Making; 2022 Oct; 42(7):872-884. PubMed ID: 35735216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gaussian process metamodeling in Bayesian value of information analysis: a case of the complex health economic model for breast cancer screening.
    Rojnik K; Naversnik K
    Value Health; 2008; 11(2):240-50. PubMed ID: 18380636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods for expected value of information analysis in complex health economic models: developments on the health economics of interferon-beta and glatiramer acetate for multiple sclerosis.
    Tappenden P; Chilcott JB; Eggington S; Oakley J; McCabe C
    Health Technol Assess; 2004 Jun; 8(27):iii, 1-78. PubMed ID: 15215017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of Hepatitis C Virus Treatment Models for People Who Inject Drugs in Opioid Agonist Treatment Programs.
    Gutkind S; Schackman BR; Morgan JR; Leff JA; Agyemang L; Murphy SM; Akiyama MJ; Norton BL; Litwin AH; Linas BP
    Clin Infect Dis; 2020 Mar; 70(7):1397-1405. PubMed ID: 31095683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of generic pan-genotypic sofosbuvir/velpatasvir versus genotype-dependent direct-acting antivirals for hepatitis C treatment.
    Goel A; Chen Q; Chhatwal J; Aggarwal R
    J Gastroenterol Hepatol; 2018 Dec; 33(12):2029-2036. PubMed ID: 29864213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population.
    Chahal HS; Marseille EA; Tice JA; Pearson SD; Ollendorf DA; Fox RK; Kahn JG
    JAMA Intern Med; 2016 Jan; 176(1):65-73. PubMed ID: 26595724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of Machine Learning Techniques to an Agent-Based Model of
    Chen SH; Londoño-Larrea P; McGough AS; Bible AN; Gunaratne C; Araujo-Granda PA; Morrell-Falvey JL; Bhowmik D; Fuentes-Cabrera M
    Front Microbiol; 2021; 12():726409. PubMed ID: 34630352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linear regression metamodeling as a tool to summarize and present simulation model results.
    Jalal H; Dowd B; Sainfort F; Kuntz KM
    Med Decis Making; 2013 Oct; 33(7):880-90. PubMed ID: 23811758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BayCANN: Streamlining Bayesian Calibration With Artificial Neural Network Metamodeling.
    Jalal H; Trikalinos TA; Alarid-Escudero F
    Front Physiol; 2021; 12():662314. PubMed ID: 34113262
    [No Abstract]   [Full Text] [Related]  

  • 16. The cost-effectiveness of testing for hepatitis C in former injecting drug users.
    Castelnuovo E; Thompson-Coon J; Pitt M; Cramp M; Siebert U; Price A; Stein K
    Health Technol Assess; 2006 Sep; 10(32):iii-iv, ix-xii, 1-93. PubMed ID: 16948891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When Is Mass Prophylaxis Cost-Effective for Epidemic Control? A Comparison of Decision Approaches.
    Malloy GSP; Brandeau ML
    Med Decis Making; 2022 Nov; 42(8):1052-1063. PubMed ID: 35591754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspective.
    Kim HL; Kim KA; Choi GH; Jang ES; Ki M; Choi HY; Jeong SH
    Clin Mol Hepatol; 2022 Jan; 28(1):91-104. PubMed ID: 34736311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational Intelligence and Wavelet Transform Based Metamodel for Efficient Generation of Not-Yet Simulated Waveforms.
    Oltean G; Ivanciu LN
    PLoS One; 2016; 11(1):e0146602. PubMed ID: 26745370
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.